As people around the world mark Earth Day (April 22) with activities that protect the planet, our cells are busy safeguarding their own environment.
To keep themselves neat, tidy and above all healthy, cells rely on a variety of recycling and trash removal systems. If it weren't for these systems, cells could look like microscopic junkyards—and worse, they might not function properly. Scientists funded by the National Institutes of Health are therefore working to understand the cell's janitorial services to find ways to combat malfunctions.
Office of Biological and Environmental Research of the U.S. Department of Energy Office of Science.
When proteins enter the proteasome, they're chopped into bits for re-use.
Garbage Disposal and Recycling Plant
One of the cell's trash processors is called the proteasome. It breaks down proteins, the building blocks and mini-machines that make up many cell parts. The barrel-shaped proteasome disassembles damaged or unwanted proteins, breaking them into bits that the cell can re-use to make new proteins. In this way, the proteasome is just as much a recycling plant as it is a garbage disposal.
How does the cell know which proteins to keep and which to trash? The 2004 Nobel Prize in chemistry went to three scientists for answering that question. They found that the cell labels its refuse with a tiny protein tag called ubiquitin. Once a protein has the ubiquitin label, the proteasome can grab it, put it inside the barrel, break it down and release the pieces.
Because diseases like Alzheimer's involve the accumulation of excess proteins, researchers are trying to develop medicines to help the proteasome out. They hope such a treatment would keep brain cells clean and healthy.
Scientists are also interested in designing medicines that turn off the proteasome. Cancer cells, for instance, make a lot of abnormal proteins that their proteasomes have to remove. A proteasome-clogging medicine could prevent cancer cells from recycling their own garbage, leaving them without reusable resources for survival and growth. This is the approach behind the proteasome inhibitor drug bortezomib, which is used for the blood cancer multiple myeloma.
Proteins aren't the only type of cellular waste. Cells also have to recycle compartments called organelles when they become old and worn out. For this task, they rely on an organelle called the lysosome, which works like a cellular stomach. Containing acid and several types of digestive enzymes, lysosomes digest unwanted organelles in a process termed autophagy, from the Greek words for "self" and "eat." The multipurpose lysosome also processes proteins, bacteria and other "food" the cell has engulfed.
An inability to make one of the lysosomal enzymes can lead to a rare, life-threatening sickness called a lysosomal storage disease. There are more than 40 different lysosomal storage diseases, depending on the kind of trash that's unprocessed. These diseases can affect many organs, including the brain, heart and bones.
Lysosomes also gobble up viruses, an activity important to fighting infections. A drug that activates lysosomes protects mice from diseases like West Nile virus. It's possible that the same or similar medications might treat diseases in which cellular trash piles up, including Alzheimer's and other diseases of aging.
While cells mainly use proteasomes and lysosomes, they have a couple of other options for trash disposal.
Sometimes they simply hang onto their trash, performing the cellular equivalent of sweeping it under the rug. Scientists propose that the cell may pile all the unwanted proteins together in a glob called an aggregate to keep them from gumming up normal cellular machinery.
For example, a protein called islet amyloid polypeptide builds up in aggregates in the pancreas of people with type 2 diabetes. Other proteins form aggregates in certain brain diseases. Scientists are still trying to understand what these trash piles do and whether they're helpful or harmful.
If the garbage can't be digested by lysosomes, the cell can sometimes spit it out in a process called exocytosis. Once outside the cell, the trash may encounter enzymes that can take it apart, or it may simply form a garbage heap called a plaque. Unfortunately, these plaques outside the cell may be harmful, too.
The cell also has ways to toss out some poisons that get inside. This means that cancer cells may pump out cancer drugs that are meant to destroy them, and bacteria may do the same with antibiotics. Scientists are studying how these pumps work, looking for ways to keep the medicines inside where they can do their job.
Further study of the many ways cells take out the trash could lead to new approaches for keeping them healthy and preventing or treating disease.
Inside the Cell Booklet http://publications.nigms.nih.gov/insidethecell/
Shelly Pollard |
Gene switch may repair DNA and prevent cancer
12.02.2016 | Institute for Integrated Cell-Material Sciences at Kyoto University
New method opens crystal clear views of biomolecules
11.02.2016 | Deutsches Elektronen-Synchrotron DESY
Today, plants and microorganisms are heavily used for the production of medicinal products. The production of biopharmaceuticals in plants, also referred to as “Molecular Pharming”, represents a continuously growing field of plant biotechnology. Preferred host organisms include yeast and crop plants, such as maize and potato – plants with high demands. With the help of a special algal strain, the research team of Prof. Ralph Bock at the Max Planck Institute of Molecular Plant Physiology in Potsdam strives to develop a more efficient and resource-saving system for the production of medicines and vaccines. They tested its practicality by synthesizing a component of a potential AIDS vaccine.
The use of plants and microorganisms to produce pharmaceuticals is nothing new. In 1982, bacteria were genetically modified to produce human insulin, a drug...
Atomic clock experts from the Physikalisch-Technische Bundesanstalt (PTB) are the first research group in the world to have built an optical single-ion clock which attains an accuracy which had only been predicted theoretically so far. Their optical ytterbium clock achieved a relative systematic measurement uncertainty of 3 E-18. The results have been published in the current issue of the scientific journal "Physical Review Letters".
Atomic clock experts from the Physikalisch-Technische Bundesanstalt (PTB) are the first research group in the world to have built an optical single-ion clock...
The University of Würzburg has two new space projects in the pipeline which are concerned with the observation of planets and autonomous fault correction aboard satellites. The German Federal Ministry of Economic Affairs and Energy funds the projects with around 1.6 million euros.
Detecting tornadoes that sweep across Mars. Discovering meteors that fall to Earth. Investigating strange lightning that flashes from Earth's atmosphere into...
Physicists from Saarland University and the ESPCI in Paris have shown how liquids on solid surfaces can be made to slide over the surface a bit like a bobsleigh on ice. The key is to apply a coating at the boundary between the liquid and the surface that induces the liquid to slip. This results in an increase in the average flow velocity of the liquid and its throughput. This was demonstrated by studying the behaviour of droplets on surfaces with different coatings as they evolved into the equilibrium state. The results could prove useful in optimizing industrial processes, such as the extrusion of plastics.
The study has been published in the respected academic journal PNAS (Proceedings of the National Academy of Sciences of the United States of America).
Exceeding critical temperature limits in the Southern Ocean may cause the collapse of ice sheets and a sharp rise in sea levels
A future warming of the Southern Ocean caused by rising greenhouse gas concentrations in the atmosphere may severely disrupt the stability of the West...
12.02.2016 | Event News
09.02.2016 | Event News
02.02.2016 | Event News
12.02.2016 | Physics and Astronomy
12.02.2016 | Life Sciences
12.02.2016 | Medical Engineering